High Outlier
Strength
40 mg/1
Manufacturer
Galderma Laboratories, L.P.NDC
00299382230
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
DOXYCYCLINEApproval Type
New Drug (NDA)
FDA Application
NDA050805On Market Since
5/14/2010
Pharmacological Classes
Tetracycline-class Drug
Tetracyclines
Related Drugs
Same classification